Skip to content

Study · Animal study (in vivo) · goat · 1994

4 results

Delayed luteolysis and suppression of testosterone secretion after recombinant ovine interferon treatment in goats (Capra hircus).

Homeida AM, al-Afaleq AI

Journal of reproduction and fertility1 Nov 1994Cited by 5 (Europe PMC)

PMID7861381 (opens in a new tab)DOI10.1530/jrf.0.1020301 (opens in a new tab)PepBankPUB-07861381
Source linkPubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In goats, subcutaneous oxytocin significantly increased testosterone secretion compared with saline.

    In plain wordsIn goats, oxytocin injections raised testosterone release more than saline injections.

    Peptide
    Oxytocin
    Outcome
    IncreaseTestosterone secretion
    Study

    goatn: not reported in source

    Comparator
    Saline
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    100 iu · subcutaneous · daily from day 3 to day 6 of the oestrous cycleAs given in this study (goat).

    Source sentences

    Summary
    Oxytocin at a dose of 100 iu injected s.c. daily into goats (Capra hircus) between day 3 and day 6 of the oestrous cycle caused a significant increase in testosterone secretion and luteolysis compared with saline-treated animals.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In goats, subcutaneous oxytocin caused significant luteolysis compared with saline.

    In plain wordsIn goats, oxytocin injections caused more breakdown of the corpus luteum than saline injections.

    Peptide
    Oxytocin
    Outcome
    IncreaseLuteolysis
    Study

    goatn: not reported in source

    Comparator
    Saline
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    100 iu · subcutaneous · daily from day 3 to day 6 of the oestrous cycleAs given in this study (goat).

    Source sentences

    Summary
    Oxytocin at a dose of 100 iu injected s.c. daily into goats (Capra hircus) between day 3 and day 6 of the oestrous cycle caused a significant increase in testosterone secretion and luteolysis compared with saline-treated animals.

Studies that did not test the peptide alone2

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 03AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Efficacy outcome

    In goats, recombinant ovine interferon tau given with oxytocin delayed luteolysis; oxytocin served as the challenge.

    In plain wordsIn goats, interferon tau given with oxytocin delayed corpus luteum breakdown. Oxytocin was the challenge, not the treatment.

    Peptide
    Oxytocin
    Outcome
    DecreaseLuteolysis with oxytocin plus interferon tau
    Study

    goatn: not reported in source

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    or concomitantly (80 micrograms day-1) with oxytocin between day 3 and day 7, delayed luteolysis

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 04AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Efficacy outcome

    In goats, recombinant ovine interferon tau given with oxytocin blocked the oxytocin-induced increase in testosterone release.

    In plain wordsIn goats, interferon tau given with oxytocin blocked the rise in testosterone release. Oxytocin was the challenge, not the treatment.

    Peptide
    Oxytocin
    Outcome
    DecreaseTestosterone release with oxytocin plus interferon tau
    Study

    goatn: not reported in source

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    or concomitantly (80 micrograms day-1) with oxytocin between day 3 and day 7, delayed luteolysis and blocked the increased release of testosterone

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.